CS135591A2 - Method of peptide preparation - Google Patents

Method of peptide preparation

Info

Publication number
CS135591A2
CS135591A2 CS911355A CS135591A CS135591A2 CS 135591 A2 CS135591 A2 CS 135591A2 CS 911355 A CS911355 A CS 911355A CS 135591 A CS135591 A CS 135591A CS 135591 A2 CS135591 A2 CS 135591A2
Authority
CS
Czechoslovakia
Prior art keywords
peptide preparation
peptide
preparation
Prior art date
Application number
CS911355A
Other languages
English (en)
Inventor
Tamotsu Hashimoto
Atsushi Tsujimura
Shigezo Udaka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of CS135591A2 publication Critical patent/CS135591A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y10S435/833—Bacillus brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CS911355A 1990-05-11 1991-05-08 Method of peptide preparation CS135591A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12216690 1990-05-11
JP2334575A JPH04126084A (ja) 1990-05-11 1990-11-30 蛋白質の製造法

Publications (1)

Publication Number Publication Date
CS135591A2 true CS135591A2 (en) 1991-12-17

Family

ID=26459349

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911355A CS135591A2 (en) 1990-05-11 1991-05-08 Method of peptide preparation

Country Status (11)

Country Link
US (1) US5232841A (cs)
EP (1) EP0531530A1 (cs)
JP (1) JPH04126084A (cs)
AU (1) AU643793B2 (cs)
CA (1) CA2082637A1 (cs)
CS (1) CS135591A2 (cs)
IE (1) IE911607A1 (cs)
IL (1) IL98095A0 (cs)
NZ (1) NZ238095A (cs)
PT (1) PT97623A (cs)
WO (1) WO1991018101A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6046294A (en) * 1993-02-22 1994-09-14 Sumitomo Pharmaceuticals Company, Limited Process for producing human growth hormone
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
JP5020487B2 (ja) * 2005-07-22 2012-09-05 ヒゲタ醤油株式会社 融合タンパク質発現用新規ｄｎａ及び該ｄｎａを用いたタンパク質の製造方法
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
US20090280103A1 (en) * 2008-04-04 2009-11-12 Martin Flueck Regulation of muscle repair
CA2765849A1 (en) 2009-07-02 2011-01-06 Verdezyne, Inc. Biological methods for preparing adipic acid
EP2451960A2 (en) 2009-07-09 2012-05-16 Verdezyne, Inc. Engineered microorganisms with enhanced fermentation activity
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
MY184871A (en) 2011-07-06 2021-04-28 Radici Chimica S P A Biological methods for preparing a fatty dicarboxylic acid
MY175858A (en) 2012-12-19 2020-07-14 Corvay Bioproducts Gmbh Biological methods for preparing a fatty dicarboxylic acid
CN105121624A (zh) 2012-12-19 2015-12-02 沃德金有限公司 制备脂肪二羧酸的生物学方法
TWI638047B (zh) 2014-04-09 2018-10-11 史基普研究協會 藉由核酸三磷酸酯轉運子將非天然或經修飾的核苷三磷酸酯輸入至細胞中
WO2016154046A2 (en) 2015-03-20 2016-09-29 Verdezyne, Inc. Biological methods for preparing 3-hydroxypropionic acid
SG11202000167SA (en) 2017-07-11 2020-02-27 Synthorx Inc Incorporation of unnatural nucleotides and methods thereof
CA3069697A1 (en) 2017-07-13 2019-01-17 Radici Chimica S.P.A. Biological methods for modifying cellular carbon flux
KR20250145137A (ko) 2017-08-03 2025-10-13 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
WO2020060948A1 (en) 2018-09-17 2020-03-26 Levadura Biotechnology, Inc. Production of cannabinoids in yeast using a fatty acid feedstock
US20200246467A1 (en) 2019-02-06 2020-08-06 Synthorx, Inc. Il-2 conjugates and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326046A3 (en) * 1988-01-25 1990-06-13 Takeda Chemical Industries, Ltd. Production of human epidermal growth factor

Also Published As

Publication number Publication date
AU643793B2 (en) 1993-11-25
EP0531530A1 (en) 1993-03-17
AU7762691A (en) 1991-12-10
US5232841A (en) 1993-08-03
IE911607A1 (en) 1991-11-20
WO1991018101A1 (en) 1991-11-28
CA2082637A1 (en) 1991-11-12
EP0531530A4 (cs) 1994-04-06
IL98095A0 (en) 1992-06-21
PT97623A (pt) 1992-02-28
NZ238095A (en) 1992-10-28
JPH04126084A (ja) 1992-04-27

Similar Documents

Publication Publication Date Title
EP0479306A3 (en) Preparation of polyamides from omega-aminonitriles
EP0488467A3 (en) Preparation of alkoxyalkanoic acids
PL289846A1 (en) Method of obtaining lyposome preparations containing peptides
EP0452959A3 (en) Method of application
PL294679A1 (en) Method of obtaining novel polypeptides
AU8059391A (en) Method of making peptides
EP0483597A3 (en) Process of preparation of carebastin
EP0510382A3 (en) Method of preparation of alpha-omega-aminoalcohols
NZ238916A (en) Preparation of 1-hydroxymethylpyrazoles
NZ240279A (en) Preparation of
OA09567A (en) Method of preparing polyethercyclicpolyols
EP0505002A3 (en) Method of preparing polyethercyclicpolyols
PL283907A1 (en) Method of obtaining oligoestrols
ZA916093B (en) Preparation of 2-amino-4-alkoxy-s-triazines
GB9005839D0 (en) Preparation of fluoroanilines
CS275182B2 (en) Method of 1-methoxy-2-propanone preparation
CS245490A2 (en) Method of 4-benzyloxy-4 -hydroxydifenylsulphon preparation
PL290102A1 (en) Method of obtaining peptides
GB9111703D0 (en) Method of transsilylation
NZ237062A (en) Preparation of cis-beta-lactams
RO105574B1 (ro) Procedeu de obtinere a dimetildiclorsilanului
CS279089A1 (en) Method of 1-amino-7-naphthol preparation
GB9010740D0 (en) Peptide compounds and their preparation
CS841188A1 (en) Method of trisdiethylaminosiliciumchloride preparation
CS249789A1 (en) Method of n-protected peptine alcihols preparation